ストックスクリーナーアプリを入手
0.92
7.06%
-0.0699
前日終値:
$0.9899
開ける：
$0.9716
24時間の取引高:
98,312
Relative Volume:
0.03
時価総額：
$17.16M
収益：
$174.80K
当期純損益:
$-8.85M
株価収益率:
-1.3359
EPS:
-0.6887
ネットキャッシュフロー:
$-4.37M
1週間 パフォーマンス:
-5.15%
1か月 パフォーマンス:
-26.98%
6か月 パフォーマンス:
-24.28%
1年 パフォーマンス:
-77.88%
1日の値動き範囲:
$0.9056
$0.9869
1週間の範囲:
$0.9056
$1.01
52週間の値動き範囲:
$0.702
$4.18
Nexalin Technology Inc Stock (NXL) Company Profile
NXL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
0.92 | 18.46M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nexalin Technology Inc (NXL) 最新ニュース
What analysts say about Nexalin Technology Inc Equity Warrant stockEarnings Miss Alerts & Superior Capital Trading Plans - earlytimes.in
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daytona Beach News-Journal
Market Overview: Will Nexalin Technology Inc stock outperform value stocksTrade Entry Report & Low Risk Investment Opportunities - moha.gov.vn
Nexalin Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Nexalin Technology unveils new investor presentation on DIFS - MSN
Nexalin Technology Unveils New Investor Presentation on DIFS - TipRanks
Nexalin Technology, Inc. Unveils Advanced Neurostimulation Technology - TradingView — Track All Markets
Will Nexalin Technology Inc. Equity Warrant stock reach Wall Street targetsTreasury Yields & Real-Time Stock Entry Alerts - Newser
Nexalin advances Alzheimer’s device after FDA meeting By Investing.com - Investing.com South Africa
Nexalin Technology completes FDA Q-submission meeting for Gen-2 Sync - marketscreener.com
Nexalin advances Alzheimer’s device after FDA meeting - Investing.com
Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program - Yahoo Finance
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4 - markets.businessinsider.com
How Nexalin Technology Inc. stock trades before earnings2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Nexalin Technology earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on December 4 - 富途牛牛
Volume Summary: Is Nexalin Technology Inc. Equity Warrant stock supported by strong cash flows2025 Technical Patterns & Smart Swing Trading Alerts - BỘ NỘI VỤ
Investors in cash trouble should check out Nexalin Technology Inc (NXL) - Setenews
Nexalin Technology (NASDAQ:NXL) Rating Lowered to Sell at Wall Street Zen - Defense World
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Nexalin Technology Inc. Equity Warrant stock near bottom after decline2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why hedge funds are buying Nexalin Technology Inc. stockEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedWeekly Market Report & Expert Curated Trade Setup Alerts - newser.com
Is Nexalin Technology Inc. Equity Warrant stock trading near support levelsEarnings Miss & Short-Term High Return Strategies - newser.com
Can Nexalin Technology Inc. stock withstand economic slowdown - newser.com
Trend analysis for Nexalin Technology Inc. this weekJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Risk vs reward if holding onto Nexalin Technology Inc.Buy Signal & High Accuracy Buy Signal Tips - newser.com
Is Nexalin Technology Inc. stock attractive for retirement portfoliosJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com
Will Nexalin Technology Inc. stock deliver better than expected guidanceQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
Should you wait for a breakout in Nexalin Technology Inc.Trade Risk Summary & High Accuracy Trade Alerts - newser.com
How Nexalin Technology Inc. Equity Warrant stock performs in rate cut cyclesPortfolio Performance Summary & Expert Verified Movement Alerts - newser.com
How to monitor Nexalin Technology Inc. Equity Warrant with trend dashboardsJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
How analysts rate Nexalin Technology Inc. stock today2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from automationJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
How to monitor Nexalin Technology Inc. with trend dashboardsIndex Update & Reliable Price Breakout Alerts - newser.com
Can Nexalin Technology Inc. stock double in next 5 years2025 Short Interest & Consistent Profit Alerts - newser.com
Can Nexalin Technology Inc. stock reach $100 price targetQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
Detecting price anomalies in Nexalin Technology Inc. Equity Warrant with AIWeekly Trend Recap & Low Risk Entry Point Guides - newser.com
Nexalin Technology Inc (NXL) 財務データ
収益
当期純利益
現金流量
EPS
Nexalin Technology Inc (NXL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
0.52%
0.28%
大文字化:
|
ボリューム (24 時間):